BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26700620)

  • 21. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
    Wild PJ; Fuchs T; Stoehr R; Zimmermann D; Frigerio S; Padberg B; Steiner I; Zwarthoff EC; Burger M; Denzinger S; Hofstaedter F; Kristiansen G; Hermanns T; Seifert HH; Provenzano M; Sulser T; Roth V; Buhmann JM; Moch H; Hartmann A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1798-806. PubMed ID: 19454613
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Rose M; Bringezu S; Godfrey L; Fiedler D; Gaisa NT; Koch M; Bach C; Füssel S; Herr A; Hübner D; Ellinger J; Pfister D; Knüchel R; Wirth MP; Böhme M; Dahl E
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UroMark-a urinary biomarker assay for the detection of bladder cancer.
    Feber A; Dhami P; Dong L; de Winter P; Tan WS; Martínez-Fernández M; Paul DS; Hynes-Allen A; Rezaee S; Gurung P; Rodney S; Mehmood A; Villacampa F; de la Rosa F; Jameson C; Cheng KK; Zeegers MP; Bryan RT; James ND; Paramio JM; Freeman A; Beck S; Kelly JD
    Clin Epigenetics; 2017; 9():8. PubMed ID: 28163793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
    Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.
    Reinert T; Modin C; Castano FM; Lamy P; Wojdacz TK; Hansen LL; Wiuf C; Borre M; Dyrskjøt L; Orntoft TF
    Clin Cancer Res; 2011 Sep; 17(17):5582-92. PubMed ID: 21788354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
    Mlcochova H; Hezova R; Stanik M; Slaby O
    Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer.
    Luo ZG; Li ZG; Gui SL; Chi BJ; Ma JG
    J Int Med Res; 2014 Feb; 42(1):35-41. PubMed ID: 24366498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness.
    Feng CC; Wang PH; Guan M; Jiang HW; Wen H; Ding Q; Wu Z
    Folia Biol (Praha); 2011; 57(6):242-7. PubMed ID: 22264718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
    Lin SY; Linehan JA; Wilson TG; Hoon DSB
    Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.
    Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
    Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.
    Mengual L; Lozano JJ; Ingelmo-Torres M; Gazquez C; Ribal MJ; Alcaraz A
    Int J Cancer; 2013 Dec; 133(11):2631-41. PubMed ID: 23686449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A protocol for urine collection and storage prior to DNA methylation analysis.
    Bosschieter J; Bach S; Bijnsdorp IV; Segerink LI; Rurup WF; van Splunter AP; Bahce I; Novianti PW; Kazemier G; van Moorselaar RJA; Steenbergen RDM; Nieuwenhuijzen JA
    PLoS One; 2018; 13(8):e0200906. PubMed ID: 30142219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection.
    Jarrard WE; Schultz A; Etheridge T; Damodaran S; Allen GO; Jarrard D; Yang B
    PLoS One; 2019; 14(6):e0218950. PubMed ID: 31233548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.
    Hayashi M; Bernert H; Kagohara LT; Maldonado L; Brait M; Schoenberg M; Bivalacqua T; Netto GJ; Koch W; Sidransky D; Hoque MO
    Oncotarget; 2014 May; 5(10):3350-61. PubMed ID: 24830820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence.
    Mancini M; Righetto M; Zumerle S; Montopoli M; Zattoni F
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma.
    Mengual L; Burset M; Ribal MJ; Ars E; Marín-Aguilera M; Fernández M; Ingelmo-Torres M; Villavicencio H; Alcaraz A
    Clin Cancer Res; 2010 May; 16(9):2624-33. PubMed ID: 20406841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting DNA methylation of the BCL2, CDKN2A and NID2 genes in urine using a nested methylation specific polymerase chain reaction assay to predict bladder cancer.
    Scher MB; Elbaum MB; Mogilevkin Y; Hilbert DW; Mydlo JH; Sidi AA; Adelson ME; Mordechai E; Trama JP
    J Urol; 2012 Dec; 188(6):2101-7. PubMed ID: 23083854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.
    Fujimoto M; Arai E; Tsumura K; Yotani T; Yamada Y; Takahashi Y; Maeshima AM; Fujimoto H; Yoshida T; Kanai Y
    Epigenetics; 2020 Dec; 15(12):1289-1301. PubMed ID: 32498593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.